References
- Abakay O, Abakay A, Palanci Y, et al. Relationship between hepcidin levels and periodic limb movement disorder in patients with obstructive sleep apnea syndrome. Sleep Breath. 2015;19(2):459–466. DOI:https://doi.org/10.1007/s11325-014-1028-3.
- Fırat H, Özdemir C, Bilgin E, et al. Is hepcidin a good marker for inflammation in obstructive sleep apnea syndrome (OSAS) patients. J Turk Sleep Med. 2015;2(2):33–37. DOI:https://doi.org/10.4274/jtsm.02.009.
- Selcuk ÖT, Eyigor M, Renda L, et al. Can we use serum copeptin levels as a biomarker in obstructive sleep apnea syndrome? J Craniomaxillofac Surg. 2015;43(6):879–882. DOI:https://doi.org/10.1016/j.jcms.2015.03.031.
- Dündar Y, Tatar EÇ, Saylam G, et al. The evaluation of inflammatory process, endothelial dysfunction, and oxidative stress in sleep apnea. Ent Updates. 2014;4(2):61–65. DOI:https://doi.org/10.2399/jmu.2014002007
- Liu Y, Yu Z, Hua D, et al. Association of serum hepcidin levels with the presence and severity of obstructive sleep apnea syndrome. Med Sci Monit. 2015;21:27–31.
- Unlu C, Saylam G, Fırat H, et al. Assessment of risk factors in geriatric patients with obstructive sleep apnea-hypopnea syndrome. Turk J Geriatr. 2012;15(1): 7–11.
- Saylam G, Selçuk OT, Fırat H, et al. Presence of systemic diseases of the patients who evaluated in our center and diagnosed as obstructive sleep apnea hypopnea syndrome. KBB-Forum. 2009;8(2):28–32.
- Selcuk OT, Saylam G, Fırat H, et al. The correlation of apnea hypopnea indices with Epworth sleepiness scale scores and physical examination. KBB-Forum. 2011;10(4):62–69.
- Baysal E, Taysi S, Aksoy N, et al. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Eur Rev Med Pharmacol Sci. 2012;16(6):770–774.
- Okur HK, Pelin Z, Yuksel M, et al. Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia. Sleep Breath. 2013;17(1):365–371. DOI:https://doi.org/10.1007/s11325-012-0703-5.
- Park CH, Valore EV, Waring AJ. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806–7810.
- Lou DQ, Lesbordes JC, Nicolas G, et al. Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology. 2005;41(5):1056–1064. DOI:https://doi.org/10.1002/hep.20663.
- Kuwahara R, Kofman AV, Landis CS, et al. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology. 2008;47(6):1994–2002. DOI:https://doi.org/10.1002/hep.22218.
- Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006;131(3):788–796. DOI:https://doi.org/10.1053/j.gastro.2006.07.007.
- Troutt JS, Rudling M, Persson L, et al. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration. Clin Chem. 2012;58(8):1225–1232. DOI:https://doi.org/10.1373/clinchem.2012.186866.
- La Du BN, Aviram M, Billecke S, et al. On the physiological role(s) of the paraoxonases. Chem Biol Interact. 1999;119-120:379–388.
- Humbert R, Adler DA, Disteche CM, et al. The molecular basis of the human paraoxonase activity polymorphism. Nat Genet. 1993;3(1):73–76. DOI:https://doi.org/10.1038/ng0193-73.
- Aviram M, Rosenblat M, Bisgaier CL, et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest. 1998;101(8):1581–1590. DOI:https://doi.org/10.1172/JCI1649.
- Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21(4):473–480.
- Mackness MI, Harty D, Bhatnagar D, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 1991;86(2–3):193–199. DOI:https://doi.org/10.1016/0021-9150(91)90215-O.
- Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004;27(1):123–128.
- Vatansever E, Surmen-Gur E, Ursavas A, et al. Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath. 2011;15(3):275–282. DOI:https://doi.org/10.1007/s11325-010-0378-8.